Recall of substandard medicines in Brazil during the period 2010-2018
Background Even with all the care taken during the production process, the pharmaceutical industries are still subject to manufacturing medicines with quality deviations, generating commercialized products without the required quality and necessitating their subsequent recall from the market. The ob...
Saved in:
Main Authors: | Cristiani Lopes Capistrano Gonçalves Oliveira (Author), Virgínia Freire Machado (Author), Heitor de Freitas Tavares (Author), Gabriel Lucas Marques Ribeiro (Author), Paulo Sérgio Dourado Arrais (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Substandard, falsified and unregistered medicines in Latin America, 2017-2018
by: Robin Rojas-Cortés
Published: (2020) -
Substandard and/or counterfeit medicines for patients
by: Subhash C Arya, et al.
Published: (2007) -
Substandard and Falsified Medicines in Myanmar
by: Mirai Sakuda, et al.
Published: (2020) -
Substandard and falsified medicine screening technologies
by: Lukas Roth, et al.
Published: (2019) - Pharmacopoeia boosts the fight against substandard drugs